Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis
Clinical trial NCT01639846 · COMPLETED
Trial details
- NCT number
- NCT01639846
- Sponsor
- C.T. Development America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2012-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.